The doublespeak triggered some backlashnot only because the company is, in fact, capitalizing on the $15 billion weight-loss drug market, but because the company also didnt explicitly mention in the voiceover that it sells the compounded version of these medications (made by combining, mixing, or altering ingredients), which arent approved by the FDA
GLP-1 RA use in complicated diabetes: There is no clear evidence regarding the use of GLP-1 RA in acute myocardial infarction, although the use of these agents is encouraged in patients with asymptomatic and stable coronary artery disease (CAD)
Many also see many benefits quickly when they stay consistent with their IV drips
Therapy decisions are informed by clinical evaluation and, when required, laboratory data to ensure antioxidant support aligns with the individuals physiological demands rather than being applied generically
Nutrition plays an equally powerful role
PMID: 21525464.